Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05264857 · ClinicalTrials.gov registry record · NA
Decision Aid and Thyroid Nodules Management
A NA study of Thyroid Nodule, sponsored by Stony Brook University.
- Recruiting
- Registry status
- NA
- Development phase
- 134
- Enrollment target
- 1
- Study location
NCT05264857: Recruiting NA study of Thyroid Nodule, sponsored by Stony Brook University.
NCT05264857 is a NA study of Thyroid Nodule that is actively recruiting participants, run by Stony Brook University. The registered enrollment target is 134 participants, above the 57-participant average among 5 other Thyroid Nodule trials with a reported enrollment target (135% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05264857, a NA study of Thyroid Nodule, is actively recruiting participants, sponsored by Stony Brook University.
- RECRUITING
- Registry status
- NA
- Development phase
- 134 participants
- Enrollment target
- 1
- Study location
Study Summary
Patients with small favorable malignant or indeterminate thyroid nodules will receive information about management of thyroid nodules. Participants will be asked to complete brief surveys at the time of enrollment, shortly after the consultation appointment with the surgeon, and a few months after either the consultation or the surgery, to assess their satisfaction with their decision and decision making process. All participants will receive routine care and counseling by their endocrinologist and surgeon.
Primary Outcome
Percent of patients with congruence between treatment option and informed values based on a survey
Conditions Studied
Interventions
- BEHAVIORAL Thyroid Nodule Management Education
Study Locations (1)
New York
- Stony Brook University Cancer Center - Stony Brook
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 134 participants |
| Start Date | 2022-02-08 |
| Est. Completion | 2027-09-30 |
| Phase | NA |
What NCT05264857 shows while recruiting
NCT05264857 is an interventional study that assigns participants to a tested intervention. The registered 134 participants enrollment target is mid-sized for trials with a published cap, above the 57-participant average among 5 other Thyroid Nodule trials with a reported enrollment target (135% higher).
The record links to 1 condition, with Thyroid Nodule appearing as the primary indexed condition, and to 1 intervention - of which Thyroid Nodule Management Education is the first listed.
NCT05264857 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05264857 about?
NCT05264857 is a clinical study titled "Decision Aid and Thyroid Nodules Management". Patients with small favorable malignant or indeterminate thyroid nodules will receive information about management of thyroid nodules. Participants will be asked to complete brief surveys at the time of enrollment, shortly after the consultation appointment with the surgeon, and a few months after e...
What is the current status of trial NCT05264857?
This trial is currently recruiting. It is a NA study. The enrollment target is 134 participants. The study started on 2022-02-08. Estimated completion is 2027-09-30.
What conditions does trial NCT05264857 study?
This clinical trial studies the following conditions: Thyroid Nodule.
What interventions are being tested in trial NCT05264857?
The interventions under investigation include: Thyroid Nodule Management Education (BEHAVIORAL).
Who is sponsoring clinical trial NCT05264857?
This trial is sponsored by Stony Brook University, which has 127 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05264857 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Thyroid Nodule
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Radiofrequency Ablation Study in LatinX Patients
RECRUITING · NA
-
A Study of Multiparametric Ultrasound Imaging Methods
RECRUITING · NA
-
Prospective Evaluation of the Pulse Biosciences nPulse™ Vybrance™ Percutaneous Electrode System
RECRUITING · NA
-
TRAIL Study: Feasibility and Pilot
RECRUITING · NA
-
Diagnostic Accuracy of Shear-Wave Elastography for the Preoperative Risk Stratification of Follicular Lesions of the Thyroid
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02469662 · 134 participants · NA
Clinical Outcomes Study of the Nexel Total Elbow
- NCT03110822 · 134 participants · Phase 1
A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients
- NCT04678648 · 134 participants · Phase 1
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
- NCT05764720 · 134 participants · NA
Stereotactic Adaptive Radiation Therapy of Borderline Resectable Pancreatic Cancer an Individualized Approach
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI